PridCor Therapeutics Advances SHIELD Study Through Dual Regulatory and Scientific Milestones With Peer-Reviewed Publication and FDA IND Exemption for Long COVI…

PridCor Therapeutics, a clinical-stage biopharmaceutical company developing antiviral therapies for infection-associated ...